fbpx

Year

2017
Lund, Sweden, 08.00 CET, 2 November 2017 – BONESUPPORT™, an emerging leader in innovative injectable bio-ceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery based on its unique CERAMENT® platform today announces the publication of its Interim Report January – September 2017. Q3 Net sales increased by 23% FINANCIAL HIGHLIGHTS...
Lund, Sweden, 18:00 CET 31st October 2017 – During October, the number of shares and votes in BONESUPPORT HOLDING AB (publ) has increased due to the exercise of warrants. As of 31st October 2017, the number of shares and votes in BONESUPPORT HOLDING AB (publ) amounts to 49,900,591. For more information contact: Richard Davies, CEO Tel:...
EB8018 is an oral small molecule targeting the host-microbiome interaction by blocking FimH   PARIS and CAMBRIDGE, Massachusetts, October 27, 2017 /PRNewswire/ — ENTEROME SA, a pioneer of innovative therapies for microbiome-related diseases, is pleased to announce the successful completion of the first Phase 1 clinical study with its lead candidate EB8018, a small molecule designed to block...
Saint-Priest, France, October 27, 2017 – Biom’Up, specialist of surgical hemostasis, today provides a regulatory update regarding the United States Food and Drug Administration’s (FDA) review of the company’s Premarket Approval (PMA) application for its HEMOBLASTTM Bellows. The FDA conducted a PMA pre-approval inspection at the Biom’up Saint Priest, France, manufacturing facility. The four-day Premarket...
Er du medicinstuderende med en stor interesse for forskning, og vil du bruge 10 måneder i San Francisco? Netop nu er der åbent for ansøgninger til fjerde runde af Lundbeckfondens fellowship-program, der hvert år sender nogle af Danmarks dygtigste medicinstuderende over Atlanten til Stanford University og University of San Francisco California for at lære af...
Press release Biom’Up announces the success of its IPO, raising close to €38.1 million on Euronext Paris First initial public offering in the healthcare sector on the Euronext regulated market in Paris in the last 6 months Strong institutional demand in France as well as abroad, especially in the United States and the United Kingdom:...
Operationskonceptet ”Fast-track” har på 20 år revolutioneret de fleste operationsforløb og forkortet længden af indlæggelser markant. Fx er knæ- og hofteoperationer gået fra et hospitaliseringsbehov på ca. 10 dage til nu 0-2 dage. Resultatet af Fast-track er ikke kun en stor økonomisk samfundsmæssig gevinst – patienterne får også et bedre og mere sikkert forløb. Men...
BIO Buzz Center with Ciara Kennedy – President & CEO, Amplyx Pharmaceuticals, Inc. at the 2017 BIO Investor Forum in San Francisco.
Lund, Sweden, 08:00 CEST 19 October 2017 – BONESUPPORT™ an emerging leader in innovative injectable bio-ceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery based on its unique CERAMENT® platform, will publish its Q3 2017 Interim Report on Thursday 2 November 2017 at 08.00am CEST. The Company will...
Planter kan noget ganske særligt. De kan udnytte solens energi til at producere alle de organiske stoffer, de har brug for til deres vækst og udvikling samt til at forsvare sig mod sygdomme og dyr. Alt det klarer planterne baseret på deres evne til at udføre fotosyntese. Typisk producerer planter dog meget små mængder af...
1 2 3 4 5 6 14

Nyheder

Hjernestimulation skal lindre symptomer ved Parkinsons sygdom
25. januar 2021
Minihjerner skal kaste lys over nervesygdomme
25. januar 2021
Mekanismer bag skizofreni
25. januar 2021

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge